← All trials
NCT04530357
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 19, 2020
- Primary completion
- Nov 25, 2020
- Completion date
- Nov 30, 2020
- First posted
- Aug 28, 2020
- Last posted
- Dec 24, 2020
- Enrollment
- 244
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Research Institute for Biological Safety ProblemsLead sponsor
- Research Institute for Biological Safety ProblemsStudy director
- Research Institute for Biological Safety ProblemsStudy chair
- Government of KazakhstanCollaborator
- Government of KazakhstanStudy director
- Government of KazakhstanStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.